This detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand.
Providing:
- A thorough review of the burgeoning market for biopharmaceutical drugs in South East Asia - An examination of the markets in terms of investment and research opportunities - Market forecasts to 2013 for biopharmaceuticals - A review of over 65 local companies/ organisations developing biopharmaceutical products
Markets covered:
- Indonesia - Malaysia - Singapore - South Korea - Taiwan - Thailand
